Align Technology 미래 성장

Future 기준 확인 2/6

Align Technology (는) 각각 연간 17.3% 및 7.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 18% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 19.6% 로 예상됩니다.

주요 정보

17.3%

수익 성장률

18.0%

EPS 성장률

Medical Equipment 수익 성장	16.8%
매출 성장률	7.4%
향후 자기자본 수익률	19.6%
애널리스트 커버리지	Good
마지막 업데이트	26 Dec 2024

최근 미래 성장 업데이트

Recent updates

Align Technology: A Change In Plans After Mixed Q3 Earnings

Oct 27

Is Now The Time To Look At Buying Align Technology, Inc. (NASDAQ:ALGN)?

Oct 22

Align Technology, Inc. (NASDAQ:ALGN) Shares Could Be 31% Below Their Intrinsic Value Estimate

Oct 07

Align Technology (NASDAQ:ALGN) Is Reinvesting At Lower Rates Of Return

Sep 22

Shareholders Should Be Pleased With Align Technology, Inc.'s (NASDAQ:ALGN) Price

Jul 15

Align Technology: The Short-Sellers Are Wrong

Jul 14

Is There An Opportunity With Align Technology, Inc.'s (NASDAQ:ALGN) 26% Undervaluation?

Jun 30

Is There Now An Opportunity In Align Technology, Inc. (NASDAQ:ALGN)?

Jun 11

Align Technology (NASDAQ:ALGN) Will Want To Turn Around Its Return Trends

May 27

Align Technology: International Strength To Continue Driving Growth Acceleration

May 07

수익 및 매출 성장 예측

NasdaqGS:ALGN - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	4,647	652	827	931	15
12/31/2025	4,271	555	757	802	17
12/31/2024	4,006	433	595	625	16
9/30/2024	3,961	442	373	499	N/A
6/30/2024	3,943	447	405	523	N/A
3/31/2024	3,917	462	492	615	N/A
12/31/2023	3,862	445	608	786	N/A
9/30/2023	3,807	363	686	884	N/A
6/30/2023	3,737	314	612	863	N/A
3/31/2023	3,705	315	469	738	N/A
12/31/2022	3,735	362	277	569	N/A
9/30/2022	3,864	511	349	697	N/A
6/30/2022	3,990	619	389	785	N/A
3/31/2022	4,031	706	531	976	N/A
12/31/2021	3,953	772	771	1,173	N/A
9/30/2021	3,756	740	936	1,281	N/A
6/30/2021	3,474	698	895	1,137	N/A
3/31/2021	2,816	458	727	880	N/A
12/31/2020	2,472	1,776	507	662	N/A
9/30/2020	2,287	1,738	355	499	N/A
6/30/2020	2,160	1,701	373	522	N/A
3/31/2020	2,409	1,889	479	640	N/A
12/31/2019	2,407	443	598	747	N/A
9/30/2019	2,291	419	609	770	N/A
6/30/2019	2,189	417	444	632	N/A
3/31/2019	2,079	376	394	595	N/A
12/31/2018	1,966	400	331	555	N/A
9/30/2018	1,854	313	237	476	N/A
6/30/2018	1,734	295	N/A	498	N/A
3/31/2018	1,600	258	N/A	468	N/A
12/31/2017	1,473	231	N/A	439	N/A
9/30/2017	1,345	269	N/A	357	N/A
6/30/2017	1,239	238	N/A	299	N/A
3/31/2017	1,151	219	N/A	265	N/A
12/31/2016	1,080	190	N/A	248	N/A
9/30/2016	1,017	191	N/A	246	N/A
6/30/2016	946	167	N/A	246	N/A
3/31/2016	886	148	N/A	233	N/A
12/31/2015	845	144	N/A	238	N/A
9/30/2015	814	135	N/A	230	N/A
6/30/2015	796	145	N/A	238	N/A
3/31/2015	779	150	N/A	245	N/A
12/31/2014	762	146	N/A	227	N/A
9/30/2014	740	149	N/A	222	N/A
6/30/2014	714	145	N/A	210	N/A
3/31/2014	684	139	N/A	194	N/A
12/31/2013	660	64	N/A	186	N/A

애널리스트 미래 성장 예측

수입 대 저축률: ALGN 의 연간 예상 수익 증가율( 17.3% )이 saving rate( 2.6% 보다 높습니다. ).

수익 vs 시장: ALGN 의 연간 수익( 17.3% ) US 시장( 15.3% 보다 빠르게 성장할 것으로 예상됩니다. 15.3% 연간).

고성장 수익: ALGN 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: ALGN 의 수익(연간 7.4% ) US 시장( 9.2% 보다 느리게 성장할 것으로 예상됩니다. 9.2% 연간).

고성장 수익: ALGN 의 수익(연간 7.4% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: ALGN 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 19.6 %).

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/26 23:30
장 마감 주가	2024/12/26 00:00
수익	2024/09/30
연간 수익	2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Align Technology, Inc. 49 애널리스트 중 17 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Jeffrey Johnson	Baird
Ishan Majumdar	Baptista Research
Charley Jones	Barrington Research Associates, Inc.

Align Technology 미래 성장

Future 기준 확인 2/6

주요 정보

최근 미래 성장 업데이트

Align Technology, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Price target decreased by 8.4% to US$302

Align Technology, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of Fiscal 2024

Align Technology, Inc. Revises Earnings Guidance for the Fiscal Full Year 2024

Align Technology, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Price target increased by 7.9% to US$306

Recent updates

Align Technology: A Change In Plans After Mixed Q3 Earnings

Align Technology, Inc Announces the Release of the Next Innovation of Invisalign Smile Architect Software

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Align Technology, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Is Now The Time To Look At Buying Align Technology, Inc. (NASDAQ:ALGN)?

Invisalign Palatal Expander System by Align Technology, Inc. Now Available in Singapore for Skeletal and Dental Expansion in Growing Patients

Align Technology, Inc. (NASDAQ:ALGN) Shares Could Be 31% Below Their Intrinsic Value Estimate

Align Technology, Inc. Announces Court Grants Preliminary Approval of Settlement to Resolve All Outstanding Shareholder Derivative Litigation

Align Technology (NASDAQ:ALGN) Is Reinvesting At Lower Rates Of Return

Align Technology Announces New Regional Leadership Roles

Independent Chairman recently bought US$1.5m worth of stock

Price target decreased by 8.4% to US$302

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Align Technology, Inc. Provides Earnings Guidance for the Third Quarter and Full Year of Fiscal 2024

Shareholders Should Be Pleased With Align Technology, Inc.'s (NASDAQ:ALGN) Price

Align Technology: The Short-Sellers Are Wrong

Is There An Opportunity With Align Technology, Inc.'s (NASDAQ:ALGN) 26% Undervaluation?

Now 22% undervalued after recent price drop

Is There Now An Opportunity In Align Technology, Inc. (NASDAQ:ALGN)?

Align Technology (NASDAQ:ALGN) Will Want To Turn Around Its Return Trends

Now 21% undervalued after recent price drop

Align Technology, Inc. Announces Executive Appointments

Now 20% undervalued

Align Technology: International Strength To Continue Driving Growth Acceleration

Align Technology, Inc. Revises Earnings Guidance for the Fiscal Full Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Align Technology, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Align Technology, Inc., Annual General Meeting, May 22, 2024

Investors Interested In Align Technology, Inc.'s (NASDAQ:ALGN) Earnings

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Independent Director recently sold US$7.7m worth of stock

Align Technology: Prospects Are Still Murky, Although There Are Signs Of Hope

President exercised options and sold US$2.7m worth of stock

What Does Align Technology, Inc.'s (NASDAQ:ALGN) Share Price Indicate?

Another Look At Align Technology

U.S. District Court for Northern District of California Grants Summary Judgment in Favor of Align Technology, Inc. in Two Antitrust Class Action Lawsuits

Align Technology's (NASDAQ:ALGN) Strong Earnings Are Of Good Quality

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Price target increased by 7.9% to US$306

Align Technology, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024

Now 22% overvalued

Capital Allocation Trends At Align Technology (NASDAQ:ALGN) Aren't Ideal

Investor sentiment improves as stock rises 16%

Align Technology, Inc. Receives US FDA 510(K) Clearance for the Invisalign Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients Which Represent the Majority of Orthodontic Case Starts Globally

Health Canada Issues Medical Device License to Align Technology for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion

Align Technology, Inc. Announces Board Appointments

President recently bought US$1m worth of stock

President recently bought US$1m worth of stock

Investor sentiment deteriorates as stock falls 30%

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Now 30% undervalued after recent price drop

Align Technology, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023

Align Technology, Inc. (NasdaqGS:ALGN) entered into a definitive agreement to acquire additional unknown stake in Cubicure GmbH for €79 million.

Superior Court of California, County of Santa Clara, Confirms $63 Million Arbitration Award in Favor of Align Technology and Denies SmileDirectClub’s Motion to Vacate

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 12% to US$381

Align Technology, Inc. Provides Revenue Guidance for the Third Quarter and Full Year of 2023

Align Technology, Inc.(NasdaqGS:ALGN) dropped from Russell 1000 Value Index

Independent Director recently bought US$2.0m worth of stock

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

President exercised options and sold US$2.5m worth of stock

President recently bought US$1m worth of stock

Align Technology, Inc. Announces Executive Changes in iTero Scanner and Services

Full year 2022 earnings: EPS misses analyst expectations

Price target increased by 24% to US$314

Investor sentiment improves as stock rises 37%

Align Technology, Inc. (NasdaqGS:ALGN) announces an Equity Buyback for $1,000 million worth of its shares.

Align Technology, Inc. to Report Q4, 2022 Results on Feb 01, 2023

DentalMonitoring SAS Files Patent Infringement Lawsuit Asserting Three Patents Against Align Technology, Inc